Isoniazid preventive therapy during infancy does not adversely effect growth among HIV-exposed uninfected children: secondary analysis of data from a randomized controlled trial

BACKGROUND: Isoniazid preventive therapy (IPT) decreases risk of tuberculosis (TB) disease; impact on long-term infant growth is unknown. In a recent randomized trial (RCT), we assessed IPT effects on infant growth without known TB exposure. METHODS: The infant TB Infection Prevention Study (iTIPS)...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherkos, Ashenafi S., LaCourse, Sylvia M., Enquobahrie, Daniel A., Escudero, Jaclyn N., Mecha, Jerphason, Matemo, Daniel, Kinuthia, John, John-Stewart, Grace
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614991/
https://www.ncbi.nlm.nih.gov/pubmed/37905041
http://dx.doi.org/10.1101/2023.10.19.23297259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614991/
https://www.ncbi.nlm.nih.gov/pubmed/37905041
http://dx.doi.org/10.1101/2023.10.19.23297259

Ejemplares similares